Vaccines against Coxiella infection

References

• Maurin M, Raoult D. Q fever. Clin. Microbiol. Rev. 12,518–553 (1999).
   PubMed Web of Science ®Google Scholar
• Raoult D. Treatment of Q fever. Antimicrob. Agents Chemother. 37, 1733–1736 (1993).
   PubMed Web of Science ®Google Scholar
• Kimbrough RC 3rd, Ormsbee RA, Peacock M et al. Q fever endocarditis in the United States. Ann. Intern. Med. 91,400-402 (1979).
   Google Scholar
• Raoult D, Levy PY, Harle Jr et al. Chronic Q fever: diagnosis and follow-up. Ann. NY Acad. Scl. 590, 51–60 (1990).
   PubMed Web of Science ®Google Scholar
• Baca OG, Paretsky D. Q fever and Cadella burnetit. a model for host-parasite interactions. Microbiol. Rev. 47,127–149 (1983).
   Google Scholar
• Ho T, Htwe KK, Yamasaki N et al. Isolation of Coxiella burnetii from dairy cattle and ticks, and some characteristics of the isolates in Japan. Microbiol. Immunol. 39,663–671 (1995).
   PubMed Web of Science ®Google Scholar
• Komiya T, Sadamasu K, Toriniwa H et al. Epidemiological survey on the route of Coxiella burnetii infection in an animal hospital. J Infect. Chemother. 9,151–155 (2003).
   PubMedGoogle Scholar
• Muhlemann K, Matter L, Meyer B, Schopfer K. Isolation of Coxiella burnetii from heart valves of patients treated for Q fever endocarditis. j Clin. Microbiol. 33, 428–431 (1995).
   PubMed Web of Science ®Google Scholar
• Nagaoka H, Akiyama M, Sugieda M et al. Isolation of Coxiella burnetii from children with influenza-like symptoms in Japan. Microbiol. Immunol.. 40, 147–151 (1996).
   PubMed Web of Science ®Google Scholar
• Samuel JE, Frazier ME, Mallavia LP. Correlation of plasmid type and disease caused by Cadella burnetii Infect. Immun. 49,775–779 (1985).
   Google Scholar
• Hackstadt T, Peacock MG, Hitchcock PJ, Cole RL. Lipopolysaccharide variation in Coxiella burneta. intrastrain heterogeneity in structure and antigenicity. Infect. Immun. 48,359–365 (1985).
   PubMed Web of Science ®Google Scholar
• Hendrix LR, Samuel JE, Mallavia LP. Differentiation of Coxiella burnetii isolates by analysis of restriction-endonuclease-digested DNA separated by SDS-PAGE. J Gen. Microbiol. 137 (2), 269–276 (1991).
   Google Scholar
• Stein A, Raoult D. Lack of pathotype specific gene in human Coxiella burnetii isolates. Microbial. Pathogenesis 15, 177–185 (1993).
   PubMed Web of Science ®Google Scholar
• Thiele D, Willems H. Is plasmid-based differentiation of Coxiella burnetii in 'acute' and 'chronic' isolates still valid? Eur. Epidemiol. 10, 427–434 (1994).
   Web of Science ®Google Scholar
• Valkova D, Kazar J. A new plasmid (QpDV) common to Coxiella burnetii isolates associated with acute and chronic Q fever. FEMS Microbiol. Lett. 125,275–280 (1995).
   PubMed Web of Science ®Google Scholar
• Yu X, Raoult D. Serotyping Coxiella burnetii isolates from acute and chronic Q fever patients by using monoclonal antibodies. FEMS Microbiol. Lett. 117, 15–19 (1994).
   PubMed Web of Science ®Google Scholar
• Hackstadt T. Antigenic variation in the Phase I lipopolysaccharide of Coxiella burnetii isolates. Infect. Immun. 52, 337–340 (1986).
   PubMed Web of Science ®Google Scholar
• To H, Hotta A, Zhang GQ et al. Antigenic characteristics of polypeptides of Coxiella burnetii isolates. Microbiol. Immunol. 42, 81–85 (1998).
   PubMed Web of Science ®Google Scholar
• Ormsbee RA, Bell EJ, Lackman DB, Tallent G. The influence of phase on the protective potency of Q fever vaccine. J. Immunol. 92,404–412 (1964).
   PubMed Web of Science ®Google Scholar
• Williams JC, Stewart S. Identification of immunogenic proteins of Coxiella burnetii phase variants. Microbiol. 84,257–262 (1984).
   Google Scholar
• Marmion BR Ormsbee RA, Kyrkou M et al. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs. Epidemiol. Infect. 104,275–287 (1990).
   PubMed Web of Science ®Google Scholar
• Ackland JR, Worswick DA, Marmion BP. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985–1990. Med. J. Aust. 160, 704–708 (1994).
   Google Scholar
• Behymer DE, Biberstein EL, Riemann HP et al. Q fever (Coxiella burnetii) investigations in dairy cattle: challenge of immunity after vaccination. Am. J Vet. Res. 37,631–634 (1976).
   PubMed Web of Science ®Google Scholar
• Schmeer N, Muller P, Langel J et al. Q fever vaccines for animals. Zentralbl. Bakteriol. Mikrobiol. Hyg. 267,79–88 (1987).
   PubMedGoogle Scholar
• Waag DM, Kende M, Damrow TA, Wood OL, Williams JC. Injection of inactivated Phase I Coxiella burnetii increases nonspecific resistance to infection and stimulates lymphokine production in mice. Ann. NY Acad. Scl. 590, 203–214 (1990).
   Google Scholar
• Genig VA. A live vaccine 1/M-44 against Q-fever for oral use. J. Hyg. Epi. Microbiol. Immun. 12,265-273 (1968).
   Google Scholar
• Kazar J, Brezina R, Palanova A, Tvrda B, Schramek S. Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. Bull. WHO60, 389–394 (1982).
   Google Scholar
• Williams JC, Peacock MG, Waag DM et al. Vaccines against coxiellosis and Q fever. Development of a chloroform: methanol residue subunit of Phase I Coxiella burnetti for the immunization of animals. Ann. NY Acad. Sc]. 653,88-111 (1992).
   Google Scholar
• Biberstein EL, Riemann HP, Franti CE et al. Vaccination of dairy cattle against Q fever (Coxiella burnetii): results of field trials. Am. J Vet. Res. 38,189–193 (1977).
   PubMed Web of Science ®Google Scholar
• Kishimoto RA, Johnson JW, Kenyon RH et al. Cell-mediated immune responses of guinea-pigs to an inactivated Phase I Coxiella burnetlivaccine. Infect. Immun. 19, 194–198 (1978).
   PubMed Web of Science ®Google Scholar
• Kishimoto RA, Burger GT. Appearance of cellular and humoral immunity in guinea-pigs after infection with Coxiella burnetii administered in small-particle aerosols. Infect. Immun. 16,518–521 (1977).
   PubMed Web of Science ®Google Scholar
• Kishimoto RA, Gander JC. Prevalence of rickettsial antibody and cell-mediated reaction in cynomolgus monkeys (Macaca fascicularis). Lab. Anim. Scl. 30, 1016–1017 (1980).
   PubMedGoogle Scholar
• Humphres RC, Hinrichs DJ. Role of antibody in Coxiella burnetii infection. Infect. Immun. 31,641–645 (1981).
   PubMed Web of Science ®Google Scholar
• Izzo AA, Marmion BP. Variation in interferon-y responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects. Clin. Exp. Immunol. 94,507–515 (1993).
   PubMed Web of Science ®Google Scholar
• Izzo AA, Marmion BP, Hackstadt T. Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens. Clin. Exp. Immunol. 85, 98–108 (1991).
   Google Scholar
• Izzo AA, Marmion BP, Worswick DA. Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine. J Infect. Dis. 157, 781–789 (1988).
   Google Scholar
• Guigno D, Coupland B, Smith EG et al. Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever. J Clin. Microbiol.. 30, 1958–1967 (1992).
   PubMed Web of Science ®Google Scholar
• Peacock MG, Fiset P, Ormsbee RA, Wisseman CL Jr. Antibody response in man following a small intradermal inoculation with Coxiella burnetii Phase I vaccine. Acta Virol. 23,73–81 (1979).
   Google Scholar
• Peacock MG, Philip RN, Williams JC, Faulkner RS. Serological evaluation of O fever in humans: enhanced Phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect. Immun. 41, 1089–1098 (1983).
   PubMed Web of Science ®Google Scholar
• Behymer DE, Biberstein EL, Riemann HP, Franti CE, Sawyer M. Q fever (Coxiella burnetih investigations in dairy cattle: persistence of antibodies after vaccination. Am. J Vet. Res. 36,781-784 (1975).
   Google Scholar
• Worswick D, Marmion BR Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever. J Med. Microbial.. 19,281–296 (1985).
   PubMed Web of Science ®Google Scholar
• Abinanti FRABPM. Protective or neutralizing antibody in Q fever. Am. J. Hyg. 66,173–195 (1957).
   PubMedGoogle Scholar
• Lackman DB, Frommhagen LH, Jensen FW, Lennette EH. Q fever studies. Antibody patterns against Coxiella burnetii. Am. J. Hyg. 75,158–167 (1962).
   Google Scholar
• Brezina R, Kazar J. Study of the antigenic structure of Coxiella burnetii. IV. Phagocytosis and opsonization in relation to the phase of C. burnetii. Acta Viral. 9, 268–274 (1965).
   Google Scholar
• Kazar J, Skultetyova E, Brezina R. Phagocytosis of Coxiella burneti by macrophages. Acta Virologica 19,426–431 (1975).
   PubMedGoogle Scholar
• Kishimoto RA, Veltri BJ, Canonico PG, Shirey FG, Walker JS. Electron microscopic study on the interaction between normal guinea-pig peritoneal macrophages and Coxiella burnetii. Infect. Immun. 14, 1087–1096 (1976).
   Google Scholar
• Kishimoto RA, Walker JS. Interaction between Coxiella burnetii and guinea-pig peritoneal macrophages. Infect. Immun. 14, 416–421 (1976).
   PubMed Web of Science ®Google Scholar
• Kishimoto RA, Veltri BJ, Shirey FG, Canonico PG, Walker JS. Fat of Coxiella burnetti in macrophages from immune guinea-pigs. Infect. Immun. 15,601–607 (1977).
   Google Scholar
• Hinrichs DJ, Jerrells TR. In vitro evaluation of immunity to Coxiella burnetii. Immunol.. 117,996–1003 (1976).
   Web of Science ®Google Scholar
• Ascher MS, Jahrling PB, Harrington DG, Kishimoto RA, Mcgann VG. Mechanisms of protective immunogenicity of Microbial. vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. Clin. Exp. Immunol.. 41, 225–236 (1980).
   Google Scholar
• Dellacasagrande J, Capo C, Raoult D, Mege JL. IFN-y-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNE j Immunol.. 162,2259–2265 (1999).
   Google Scholar
• Howe D, Barrows LF, Lindstrom NM, Heinzen RA. Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect. Immun. 70, 5140–5147 (2002).
   PubMed Web of Science ®Google Scholar
• Turco J, Thompson HA, Winkler HH. Interferon-y inhibits growth of Coxiella burnetii in mouse fibroblasts. Infect. Immun. 45,781–783 (1984).
   Google Scholar
• Zamboni DS, Rabinovitch M. Nitric oxide partially controls Coxiella burnetii Phase II infection in mouse primary macrophages. Infect. Immun. 71, 1225–1233 (2003).
   PubMed Web of Science ®Google Scholar
• Brooks DL, Ermel RW, Franti CE et al. Q fever vaccination of sheep: challenge of immunity in ewes. Am. J. Vet. Res. 47, 1235–1238 (1986).
   PubMed Web of Science ®Google Scholar
• Krauss H. Clinical aspects and prevention of Q fever in animals. Eur. I Epidemiol. 5, 454–455 (1989).
   PubMedGoogle Scholar
• Fishbein DB, Raoult D. A cluster of Coxiella burnetii infections associated with exposure to vaccinated goats and their unpasteurized dairy products. Am. J. Trap. Med. Hyg. 47, 35–40 (1992).
   Google Scholar
• Smadel JE, Snyder MJ, Robbins FC. Vaccination against Q fever. Am.J. Hyg. 47, 71 (1948).
   Google Scholar
• Marmion BP, Ormsbee RA, Kyrkou M et al. Vaccine prophylaxis of abattoir-associated Q fever. Lancet 2,1411–1414 (1984).
   PubMed Web of Science ®Google Scholar
• Bell EJ, Lackman DB, Meis A, Hadlow WJ. Recurrent reaction at site of Q fever vaccination in a sensitized person. Milit. Med. 124,591–595 (1964).
   Google Scholar
• Luoto L, Bell JF, Casey M, Lackman DB. Q fever vaccination of human volunteers. I. The serologic and skin-test response following subcutaneous injections. Am. J. Hygiene 78,1–15 (1963).
   Google Scholar
• Stoker MG. Q fever down the drain. Br. Med. J. 1,425–427 (1957).
   PubMedGoogle Scholar
• Johnson JVV, Eddy GA, Pedersen CE, JR. Biological properties of the M-44 strain of Coxiella burnetii. J. Infect. Dis. 133, 334–338 (1976).
   Google Scholar
• Johnson JVV, Mcleod CG, Stookey JL, Higbee GA, Pedersen CE Jr. Lesions in guinea-pigs infected with Coxiella burnetii strain M-44. J Infect. Dis. 135,995-998 (1977).
   Google Scholar
• Williams JC, Cantrell JL. Biological and Immunol.ogical properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice. Infect. Immun. 35,1091-1102 (1982).
   Google Scholar
• Ascher MS, Williams JC, Berman MA. Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii Phase I and subfractions. Infect. Immun. 42,887-889 (1983).
   Google Scholar
• Williams JC, Damrow TA, Waag DM, Amano K. Characterization of a Phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice. Infect. Immun. 51,851-858 (1986).
   Google Scholar
• Waag DM, England MJ, Tammariello RF etal. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and Phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20, 2623–2634 (2002).
   PubMed Web of Science ®Google Scholar
• Fries LF, Waag DM, Williams JC. Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever. Infect. Immun. 61,1251–1258 (1993).
   Google Scholar
• Williams JC, Hoover TA, Waag DM et al. Antigenic structure of Coxiella burnetii A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever. Ann. NY Acad. Sci. 590, 370–380 (1990).
   PubMed Web of Science ®Google Scholar
• Zhang YX, Zhi N, Yu SR et al. Protective immunity induced by 67 K outer membrane protein of Phase I Coxiella burnetii in mice and guinea-pigs. Acta Viral. 38,327–332 (1994).
   PubMed Web of Science ®Google Scholar
• Hendrix LR, Mallavia LP, Samuel JE. Cloning and sequencing of Coxiella burnetii outer membrane protein gene coml. Infect. Immun. 61,470–477 (1993).
   Google Scholar
• Mo YY, Cianciotto NP, Mallavia LE Molecular cloning of a Cwdella burnetii gene encoding a macrophage infectivity potentiator (Mip) analogue. Microbiol.ogy 141(11), 2861–2871 (1995).
   Google Scholar
• Varghees S, Kiss K, Frans G, Braha O, Samuel JE. Cloning and porin activity of the major outer membrane protein P1 from Coxiella burnetii Infect. Immun. 70, 6741–6750 (2002).
   Google Scholar
• Zhang GQ, Ho T, Yamaguchi T et al. Identification of an immunodominant 28 kDa outer membrane protein of Coxiella burned] expressed by acute disease isolates but not encoded by chronic disease isolates. Infect. Immun. (2004).
   Google Scholar
• Zhang GQ, Samuel JE. Identification and cloning potentially protective antigens of Coxiella burnediusing sera from mice experimentally infected with Nine Mile Phase I. Ann. NY Acad. Sci. 990, 510–520 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang GQ, Russell KE, Samuel J. Evaluation of the protective efficacy of recombinant proteins of Coxiella burnetii in a BALB/c mouse model. Infect. Immun. (2004).
   Google Scholar
• Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Ann. Rev. Immunol.. 15, 617–648 (1997).
   PubMed Web of Science ®Google Scholar
• Huygen K. On the use of DNA vaccines for the prophylaxis of mycobacterial diseases. Infect. Immun. 71, 1613–1621 (2003).
   PubMed Web of Science ®Google Scholar